HOME >> MEDICINE >> NEWS
Future therapies for stroke may block cell death

A new therapy to re-activate silenced genes in patients who suffer from neurodegenerative diseases or stroke is being developed by researchers at the University of Illinois at Chicago and Cornell University.

During and after a stroke, certain cellular events take place that lead to the death of brain cells. Compounds that inhibit a group of enzymes called histone deacetylases can modulate gene expression, and in some cases produce cellular proteins that are actually neuroprotective -- they are able to block cell death.

"For the first time, we show which one of the 11 histone deacetylase enzymes might be the best target to achieve cellular neuroprotection," said the study's lead investigator, Alan Kozikowski, professor of medicinal chemistry and pharmacognosy and director of the drug discovery program at UIC. "This work gives us a good direction to follow in testing histone deacetylase inhibitors in animal models for diseases such as Parkinson's and Huntington's disease, and even stroke."

Stroke can cause permanent neurological damage or even death if not promptly diagnosed and treated. It is the third-leading cause of death and the leading cause of adult disability in the United States.

A great deal of research has gone into developing histone deacetylase inhibitors as novel therapeutics, but the majority of the work has been directed toward cancer, Kozikowski said -- in which case, paradoxically, the compounds are employed to stimulate the death of rapidly multiplying cells. The molecule known as SAHA recently received approval by the Food and Drug Administration for use in cancer therapy and is the first of the histone deacetylase inhibitors to be marketed.

"The use of histone deacetylase inhibitors in medicine would thus appear to hold tremendous promise," Kozikowski said. But to be clinically useful, he said, drugs must be designed that are able to discriminate between various forms of histone deacetylase. '"/>

Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
13-Jun-2007


Page: 1 2

Related medicine news :

1. Colon cancer screening -- Going Back To The Future?
2. CHPA president and leading physician available to comment on NIDA Monitoring the Future
3. CHPA statement regarding Monitoring the Future findings on cough medicine abuse
4. Future of nanotechnology discussed by experts
5. Future of cancer research in Europe under threat
6. Future of pain therapies at forefront of physician meeting
7. New TB test scoops top prize at Medical Futures competition
8. Mayo Clinic creates Office of the Future
9. Rice, NC State win NAS/Keck Futures funding
10. Antifolate therapies found effective against certain type of malaria
11. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... February 21, 2020 , ... The American ... Cancer Leaders’ Summit in Boston, MA, in October 2021. The prestigious, invitation-only event—organized ... including prime ministers, ministers of health, city and industry leaders, senior executives and ...
(Date:2/20/2020)... ... February 20, 2020 , ... Millennial women are flocking to cosmetic surgeons ... Milford, Penn requesting treatments to achieve “ Rich Girl Face .” In fact, Glamour ... is slowing down into 2020. It’s a look inspired by the signature bee-stung lips, ...
(Date:2/19/2020)... ... 2020 , ... The American College of Lifestyle Medicine (ACLM) ... Residency Curriculum (LMRC). The curriculum is the first comprehensive, applicable and flexible Lifestyle ... resident involvement, the curriculum has included residents in every aspect of its creation ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... consistency of healthcare delivery, announced that it will participate in the HIMSS20 ... Florida. BPM+ Health will engage healthcare professionals and other stakeholders at HIMSS20 – ...
(Date:2/16/2020)... ... February 16, 2020 , ... ... it is partnering with AABB and The Joint Commission to provide a complimentary ... PBM teams (directors, managers, coordinators and transfusion safety officers) within U.S. hospitals. ...
Breaking Medicine News(10 mins):
(Date:2/20/2020)... PLAINS, N.J. (PRWEB) , ... February 20, 2020 , ... ... new location at 27 Mountain Blvd. in Warren, NJ on Thursday, January 16 at ... staff and local elected officials for the ribbon-cutting ceremony. Members of the public and ...
(Date:2/20/2020)... ... February 20, 2020 , ... ... government program modernization, has been selected to perform Independent Verification and Validation ... (EOHHS) Health Insurance Exchange and Integrated Eligibility System (HIX/IES) project. , EOHHS, ...
(Date:2/19/2020)... ... February 19, 2020 , ... Cancer diagnostics ... diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as well ... for molecular cancer diagnostics, including histology and assays, reached $1.6 billion, increasing 11.5% ...
Breaking Medicine Technology:
Cached News: